Malabsorption Syndrome Market Is Driven By Rising Prevalence Of Gastrointestinal Diseases

By Author: colin
Total Articles: 197
Comment this article

The malabsorption syndrome market comprises products that are used to treat conditions caused by impaired nutrient absorption from the small intestine. Some common causes of malabsorption include celiac disease, Crohn's disease, pancreatitis, liver diseases and surgical removal of parts of the stomach & intestines. Symptoms of malabsorption include diarrhea, weight loss, bloating, abdominal pain and deficiency of important vitamins & minerals. Oral rehydration solutions, probiotics, enzyme supplements, vitamins & minerals are widely used to manage malabsorption syndrome.
The Malabsorption Syndrome Market is estimated to be valued at US$ 3.42 Bn in 2024 and is expected to exhibit a CAGR of 6.8% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the malabsorption syndrome market are AbbVie Inc.,ImmunogenX, LLC,AstraZeneca,ImmusanT, Inc.,Ritter Pharmaceuticals. AbbVie Inc. dominates the market with its wide range of products for celiac disease and pancreatic enzyme replacements.
The Malabsorption Syndrome Market is driven by the growing prevalence of gastrointestinal ...
... diseases like celiac disease and inflammatory bowel disease. According to the National Foundation for Celiac Awareness, around 1% of the world's population suffers from celiac disease.
Many players are focused on expanding their geographical presence in emerging markets of Asia Pacific and Latin America. For instance, AstraZeneca launched enzyme-based medications for pancreatic diseases in major Asian countries in 2021. The increasing medical access and diagnostic rates in developing nations will support the global expansion of the malabsorption syndrome market during the forecast period.
Market Drivers
One of the key drivers for the malabsorption syndrome market is the rising geriatric population globally. Older adults above 60 years of age are more prone to gastrointestinal diseases like pancreatic insufficiency due to aging of the digestive organs. According to the United Nations, the number of people aged 60 years or above is expected to more than double by 2050. The growing elderly population will augment the demand for malabsorption syndrome drugs and supplements. Moreover, evolving lifestyles with high alcohol intake and smoking are increasing the risk of pancreatic diseases, driving the need for enzyme replacement therapies.
Geopolitical Impact On Malabsorption Syndrome Market Growth
The current geopolitical dynamics across various regions are presenting new challenges for the growth of the malabsorption syndrome market. The ongoing conflicts and economic/political instability in certain parts of Asia, Africa, and Eastern Europe have led to disruptions in trade, supply chains, and availability of healthcare resources in those areas. This is adversely impacting the diagnosis and treatment rates for malabsorption syndrome.
The healthcare infrastructure and access in many developing and underdeveloped nations remain limited. The geopolitical issues exacerbate the situation by reducing the affordability of high-quality malabsorption treatment options. This is a major concern as several regions with substantial patient populations lack adequate medical facilities and skilled workforce. Addressing these geopolitical barriers through collaborative international efforts will be crucial to expand patient reach and drive market growth in the coming years.
At the same time, the market players must devise localized strategies tailored for individual regions/countries. Partnering with local healthcare providers and governments can help improve diagnosis rates, while reducing treatment costs through equitable pricing models. Telehealth and mHealth platforms also need to be leveraged to enhance service availability in remote and conflict-affected areas. Overall, overcoming geopolitical challenges through sustainable multi-stakeholder cooperation is key for the malabsorption syndrome market to realize its full potential globally over the forecast period.
Malabsorption Syndrome Market: Regional Concentration
The malabsorption syndrome market in terms of value is currently concentrated majorly in North America and Europe. This can be attributed to the presence of advanced healthcare systems and higher diagnosis rates in countries like the United States, Canada, Germany, the United Kingdom, and France. According to recent estimates, over 40% of the global market value is accounted by these developed regional markets. This makes North America and Europe important geographies for key players to focus on.
Malabsorption Syndrome Market: Fastest Growing Region
The Asia Pacific region is expected to witness the fastest growth in the malabsorption syndrome market over the next decade. Factors such as the rising disease prevalence associated with improved diagnosis, growing healthcare spending, and increasing adoption of modern treatment modalities across major Asian countries are aiding the market expansion. Moreover, several market leaders have been foraying into Asia with targeted commercialization efforts. This is further strengthening the Asia Pacific position as the most promising emerging market for malabsorption syndrome globally.
Get more insights on this topic: https://fortunetelleroracle.com/news/malabsorption-syndrome-market-to-grow-at-6-8--owing-to-rising-prevalence-of-celiac-disease-922847

Author Bio:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163 )
What Are The Key Data Covered In This Malabsorption Syndrome Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Malabsorption Syndrome Market's growth between 2024 and 2031.
:- Accurate calculation of the size of the Malabsorption Syndrome Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Malabsorption Syndrome Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Malabsorption Syndrome Market vendors
FAQ’s
Q.1 What are the main factors influencing the Malabsorption Syndrome Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Malabsorption Syndrome Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Malabsorption Syndrome Market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it